Navneet Agnihotri

Navneet Agnihotri

Auto-generated profile, based on publicly available information

Navneet Agnihotri

Department of Biochemistry, BMS block Ⅱ, Panjab University, Sector 25, Chandigarh 160014, India

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SKSandeep Kumar
Sandeep Kumar
NANavneet Agnihotri
Navneet Agnihotri
Colorectal cancer (CRC) is the most common carcinoma of the digestive tract. The slow growing nature of CRC offers a great opportunity for prevention strategies. The concept of chemoprevention of colorectal cancer using plant derived natural products is gaining substantial attention because it is an inherently safe and cost-effective alternative to conventional cancer therapies. Piperlongumine (PL), a natural alkaloid present in Piper longum Linn has been reported to exhibit notable anticancer effects in various in vitro studies. Nonetheless, the chemopreventive potential of PL has not been studied in experimentally induced colon cancer yet. Ras/PI3K/Akt/mTOR signaling axis plays a central role in promoting tumor cell growth, proliferation and survival by inhibiting apoptosis. In the present study, we demonstrated, for the first time, the chemopreventive effects of PL in DMH + DSS induced colon carcinogenesis animal model. We showed that PL displayed potent antineoplastic activity against colon cancer cell growth by targeting Ras proteins and PI3K/Akt signaling cascade. PL mediated inhibition of tumor cell growth was associated with inhibition of Ras protein levels and its preferred companion protein PI3K levels that led to suppressed activity of Akt/NF-κB, c-Myc and cyclin D1. It was also found that PL arrested the cell cycle progression at G2/M phase and induced mitochondrial apoptotic pathway by downregulating Bcl-2 levels. Furthermore, the results of liver and kidney toxicity suggested that PL exhibit no toxicity in animals. Our results suggest that PL may be an effective chemopreventive agent for colon cancer.

25 February 2013 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
NANavneet Agnihotri
Navneet Agnihotri
SKSantosh Kumar
Santosh Kumar
KMKapil Mehta
Kapil Mehta
TGM2 is a stress-responsive gene that encodes a multifunctional and structurally complex protein called tissue transglutaminase (abbreviated as TG2 or tTG). TGM2 expression is frequently upregulated during inflammation and wounding. Emerging evidence indicates that TGM2 expression is aberrantly upregulated in multiple cancer cell types, particularly those selected for resistance to chemotherapy and radiation therapy and those isolated from metastatic sites. It is becoming increasingly evident that chronic expression of TG2 in epithelial cancer cells initiates a complex series of signaling networks which contributes to the development of drug resistance and an invasive phenotype. For example, forced or basal high expression of TG2 in mammary epithelial cells is associated with activation of nuclear transcription factor-kappa B (NF-κB), Akt, focal adhesion kinase, and hypoxia-inducible factor. All of these changes are considered hallmarks of aggressive tumors. TG2 expression is able to induce the developmentally regulated program of epithelial-to-mesenchymal transition (EMT) and to confer cancer stem cell (CSC) traits in mammary epithelial cells; both EMT and CSCs have been implicated in cancer metastasis and resistance to standard therapies. Importantly, TG2 expression in tumor samples is associated with poor disease outcome, increased drug resistance, and increased incidence of metastasis. These observations imply that TG2 plays a crucial role in promoting an aggressive phenotype in mammary epithelial cells. In this review, we discuss recent evidence that TG2-regulated pathways contribute to the aggressive phenotype in breast cancer.

1 July 2019 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
BSBhoomika Sharma
Bhoomika Sharma
NANavneet Agnihotri
Navneet Agnihotri

20 November 2013 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SKSantosh Kumar
Santosh Kumar
TDTaraka R. Donti
Taraka R. Donti
NANavneet Agnihotri
Navneet Agnihotri
KMKapil Mehta
Kapil Mehta
Aberrant glucose metabolism characterized by high levels of glycolysis, even in the presence of oxygen, is an important hallmark of cancer. This metabolic reprogramming referred to as the Warburg effect is essential to the survival of tumor cells and provides them with substrates required for biomass generation. Molecular mechanisms responsible for this shift in glucose metabolism remain elusive. As described herein, we found that aberrant expression of the proinflammatory protein transglutaminase 2 (TG2) is an important regulator of the Warburg effect in mammary epithelial cells. Mechanistically, TG2 regulated metabolic reprogramming by constitutively activating nuclear factor (NF)‐κB, which binds to the hypoxia‐inducible factor (HIF)−1α promoter and induces its expression even under normoxic conditions. TG2/NF‐κB‐induced increase in HIF‐1α expression was associated with increased glucose uptake, increased lactate production and decreased oxygen consumption by mitochondria. Experimental suppression of TG2 attenuated HIF‐1α expression and reversed downstream events in mammary epithelial cells. Moreover, downregulation of p65/RelA or HIF‐1α expression in these cells restored normal glucose uptake, lactate production, mitochondrial respiration and glycolytic protein expression. Our results suggest that aberrant expression of TG2 is a master regulator of metabolic reprogramming and facilitates metabolic alterations in epithelial cells even under normoxic conditions. A TG2‐induced shift in glucose metabolism helps breast cancer cells to survive under stressful conditions and promotes their metastatic competence.

1 October 2019 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
BSBhoomika Sharma
Bhoomika Sharma
VGVikas Gupta
Vikas Gupta
DDDivya Dahiya
Divya Dahiya
HKHemanth Kumar
Hemanth Kumar
KVKim Vaiphei
Kim Vaiphei
NANavneet Agnihotri
Navneet Agnihotri

1 November 2020 in Analytical Biochemistry
Verified
Journal Article
Closed access
ABAnu Bharti
Anu Bharti
SMSakshi Mittal
Sakshi Mittal
SRShilpa Rana
Shilpa Rana
DDDivya Dahiya
Divya Dahiya
NANavneet Agnihotri
Navneet Agnihotri
NPNirmal Prabhakar
Nirmal Prabhakar